Predicting the Need for Biopsy to Detect Clinically Significant Prostate Cancer in Patients with a Magnetic Resonance Imaging–detected Prostate Imaging Reporting and Data System/Likert ≥3 Lesion: Development and Multinational External Validation of the Imperial Rapid Access to Prostate Imaging and Diagnosis Risk ScoreMax Peters, Hashim U. Ahmed, David Eldred‐Evans et al.|European Urology|2022Cited by 38
Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer DetectionDmitri Pchejetski, Mathias Winkler, Ewan Hunter et al.|Cancers|2023Cited by 13
Patients’ Preferences for Cytoreductive Treatments in Newly Diagnosed Metastatic Prostate Cancer: The IP5-MATTER StudyMartin J. Connor, Verity Watson, Sanjeev Madaan et al.|European Urology Oncology|2024Cited by 4
Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment studyMartin J. Connor, Hashim U. Ahmed, Mesfin G. Genie et al.|BMJ Open|2021Cited by 3
Metastatic prostate cancer patients’ Attitudes towards Treatment of the local Tumour and metastasis Evaluative Research (IP5-MATTER): A multicentre, discrete choice experiment trial-in-progressMartin J. Connor, Hashim U. Ahmed, Mesfin G. Genie et al.|European Urology|2021Cited by 1